BioCentury
ARTICLE | Clinical News

VTP-34072: Additional Phase II data

January 25, 2016 8:00 AM UTC

Top-line data from the monotherapy arm of the double-blind, German Phase II trial in overweight Type II diabetics showed that once-daily oral VTP-34072 missed the “predefined primary efficacy endpoint...